pubrio
Illumina logo

Illumina

Public
+1
生物技术研究9,300+ employeesFounded 1998🇺🇸 美国
总部
🇺🇸San Diego, CA (+9)
行业
生物技术研究
员工人数
9,300+
成立年份
1998
公司类型
Public Company
排名
#2,600,114
股票代码
NASDAQ: ILMN

At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.

专长
研究行业生物技术医疗保健生物技术研究
32 / 32
活跃市场
Singapore · India · United Kingdom
0
新市场
本期无
2,056
信号
最近 90 天
-79%
势头
较上一周期
扩张评分发展中
36 / 100

全球扩张

实时
SingaporeIndiaUnited Kingdom
最多 3 个市场
最近 90 天
阶段
探索中12投入中14拓展中5规模化中1
近期动态
推进中30天
新增90天
+29个市场已锁定
已显示 32 个中的 3 个

解锁市场时间线与信号动态

活动脉搏

最近 90 天内有 2,136 个信号。

最近 90 天
招聘
99-6%
招聘
营销与公关
2033-82%
广告投放
产品与技术
4
云端足迹
+2个类别已锁定
已显示 5 个中的 3 个

市场进入时间线

该公司进入各个市场的顺序 — 从最早到最新

1
🇬🇧United Kingdom进入的第 1st 个市场 · 2019
拓展中
143 个信号
2
🇸🇬Singapore进入的第 2nd 个市场 · 2021
拓展中
235 个信号
3
🇮🇳India进入的第 3rd 个市场 · 2024
拓展中
190 个信号
+29个市场已锁定
已显示 32 个中的 3 个
当前阶段规模化中扩大本地规模
置信度43%
开始追踪于2019首个信号

近期信号

广告投放🇮🇳 India今天

The Sequence podcast EP1: Inside the global genomics leader

广告投放🇸🇬 Singapore今天

The Sequence podcast EP1: Inside the global genomics leader

注册以查看完整信号动态

了解一下

关于 Illumina 的常见问题

关于 Illumina 的业务、市场和增长信号的快速解答。

At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.

800M+
监测企业
50+
本地数据来源
16
动向信号
每日
更新频率
“企业进入市场的那一周,我们就触达他们——而不是一个季度之后。”
增长负责人 · Pubrio 上一支 500+ 人的营收团队

洞察全球企业的每一步动向。

与我们的团队预约一次动向地图导览。

pubrio

Pubrio 把横跨 200+ 个市场的扩张信号整合为一张实时图谱,让营收团队看见哪些公司正进军新市场,并把握时机。

关注

向 AI 了解 Pubrio

© 2026 Pubrio。保留所有权利。